Formulary
Interferon gamma-1b: Indications, Dosing, Side Effects and Interactions
Interferon gamma-1b clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Interferon gamma-1b: Indications, Dosing, Side Effects and Interactions
Interferon gamma-1b clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**To reduce the frequency of serious infection in chronic granulomatous disease**
- **Adult** (By Subcutaneous Injection): 50 micrograms/m 2 3 times a week.
**To reduce the frequency of serious infection in severe malignant osteopetrosis**
- **Adult** (By Subcutaneous Injection): 50 micrograms/m 2 3 times a week.
**To reduce the frequency of serious infection in chronic granulomatous disease for interferon gamma-1b**
- **Child 6 months-17 years (body surface area up to 0.6 m2)** (By subcutaneous injection): 1.5 micrograms/kg 3 times a week.
- **Child 6 months-17 years (body surface area 0.6 m2 and above)** (By subcutaneous injection): 50 micrograms/m2 3 times a week.
**To reduce the frequency of serious infection in severe malignant osteopetrosis for interferon gamma-1b**
- **Child (body surface area up to 0.6 m2)** (By subcutaneous injection): 1.5 micrograms/kg 3 times a week.
- **Child (body surface area 0.6 m2 and above)** (By subcutaneous injection): 50 micrograms/m2 3 times a week.
Cautions
For interferon gamma-1b Arrhythmias; cardiac disease; congestive heart failure; ischaemia; seizure disorders (including seizures associated with fever)
Contraindications
For interferon gamma-1b Simultaneous administration of foreign proteins including immunological products (such as vaccines)-risk of exaggerated immune response
Side effects
For interferon gamma-1b Common or very common Abdominal pain; arthralgia; back pain; chills; depression; diarrhoea; fatigue; fever; headache; nausea; rash; vomiting Frequency not known Atrioventricular block; chest discomfort; confusion; connective tissue disorders; embolism and thrombosis; gait abnormal; gastrointestinal haemorrhage; hallucination; heart failure; hepatic failure; hypertriglyceridaemia; hypoglycaemia; hyponatraemia; hypotension; influenza like illness; interstitial lung disease; myocardial infarction; neutropenia; pancreatitis; parkinsonism; proteinuria; renal failure; respiratory disorders; seizure; syncope; systemic lupus erythematosus (SLE); tachycardia; thrombocytopenia; transient ischaemic attack
Pregnancy
For interferon gamma-1b Manufacturers recommend avoid unless potential benefit outweighs risk (toxicity in animal studies).
Breast feeding
For interferon gamma-1b Manufacturers advise avoid-no information available.
Hepatic impairment
For interferon gamma-1b Manufacturer advises caution in severe impairment (increased risk of accumulation).
Renal impairment
For interferon gamma-1b Manufacturer advises caution in severe impairment-risk of accumulation.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Interferon gamma-1b in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

